Morpholin-acetamide derivatives for the treatment of inflammatory diseases

Compounds of formula (I) wherein: R represents C1-16 alkyl, C2-6alkenyl, C2-6alkynyl, C2-6alkynyl-Y -, aryl-Y -, heteroaryl-Y -, aryl-(O)t-aryl-Y -, aryl-(O)t-heteroaryl-Y -, heteroaryl-(O)t-aryl-Y -, heteroaryl-(O)t-heteroaryl-Y -, C2-6 alkenyl-Y -, aryl-O-Y -, heteroaryl-O-Y -, C1-16 alkyl-SO2-Y -...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ANCLIFF RACHAEL ANNE, HARRISON LEE ANDREW, KEELING SUZANNE ELAINE, HODGSON SIMON TEANBY, COOK CAROLINE MARY, ELDRED COLIN DAVID, GORE PAUL MARTIN, LEWELL XIAO QING, JUDD DUNCAN BRUCE, ROBERTSON GRAEME MICHAEL, SWANSON STEPHEN
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ANCLIFF RACHAEL ANNE
HARRISON LEE ANDREW
KEELING SUZANNE ELAINE
HODGSON SIMON TEANBY
COOK CAROLINE MARY
ELDRED COLIN DAVID
GORE PAUL MARTIN
LEWELL XIAO QING
JUDD DUNCAN BRUCE
ROBERTSON GRAEME MICHAEL
SWANSON STEPHEN
description Compounds of formula (I) wherein: R represents C1-16 alkyl, C2-6alkenyl, C2-6alkynyl, C2-6alkynyl-Y -, aryl-Y -, heteroaryl-Y -, aryl-(O)t-aryl-Y -, aryl-(O)t-heteroaryl-Y -, heteroaryl-(O)t-aryl-Y -, heteroaryl-(O)t-heteroaryl-Y -, C2-6 alkenyl-Y -, aryl-O-Y -, heteroaryl-O-Y -, C1-16 alkyl-SO2-Y -,M-Y -,J -Y -, -CN or C3-8 cycloalkyl-Y - or C3-8 cycloalkenyl-Y -, which cycloalkyl or cycloalkenyl may be optionally substituted by one or more hydroxyl or C1-16 Alkyl groups; R represents hydrogen or C1-16 alkyl; X represents ethylene or a group of formula CRR wherein R and R independently represent hydrogen or Calkyl or R and R may together with the carbon atom to which they are attached form a C3-8 cycloalkyl group; R and R independently represent hydrogen or C1-14 alkyl; Z represents a bond, CO, SO2, CR R (CH2)n, (CH2)nCR R , CHR (CH2)nO, CHR (CH2)nS, CHR (CH2)nOCO, CHR (CH2
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2004058923A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2004058923A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2004058923A13</originalsourceid><addsrcrecordid>eNqNzL0KwjAUhuEsDqLewwHnQmwV6iiiiOCkzuVgvtBA_kgOBe9eBy_A6V0e3rm63lLJY_IuNvyCcHAGZFDcxOImVLKpkIwgKWAJiELJkovWcwgsqbzJuAquqEs1s-wrVr8u1Pp8ehwvDXIaUPP3HyHD895qvdW7ft92h033n_oAVjo2xA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Morpholin-acetamide derivatives for the treatment of inflammatory diseases</title><source>esp@cenet</source><creator>ANCLIFF RACHAEL ANNE ; HARRISON LEE ANDREW ; KEELING SUZANNE ELAINE ; HODGSON SIMON TEANBY ; COOK CAROLINE MARY ; ELDRED COLIN DAVID ; GORE PAUL MARTIN ; LEWELL XIAO QING ; JUDD DUNCAN BRUCE ; ROBERTSON GRAEME MICHAEL ; SWANSON STEPHEN</creator><creatorcontrib>ANCLIFF RACHAEL ANNE ; HARRISON LEE ANDREW ; KEELING SUZANNE ELAINE ; HODGSON SIMON TEANBY ; COOK CAROLINE MARY ; ELDRED COLIN DAVID ; GORE PAUL MARTIN ; LEWELL XIAO QING ; JUDD DUNCAN BRUCE ; ROBERTSON GRAEME MICHAEL ; SWANSON STEPHEN</creatorcontrib><description>Compounds of formula (I) wherein: R represents C1-16 alkyl, C2-6alkenyl, C2-6alkynyl, C2-6alkynyl-Y -, aryl-Y -, heteroaryl-Y -, aryl-(O)t-aryl-Y -, aryl-(O)t-heteroaryl-Y -, heteroaryl-(O)t-aryl-Y -, heteroaryl-(O)t-heteroaryl-Y -, C2-6 alkenyl-Y -, aryl-O-Y -, heteroaryl-O-Y -, C1-16 alkyl-SO2-Y -,M-Y -,J -Y -, -CN or C3-8 cycloalkyl-Y - or C3-8 cycloalkenyl-Y -, which cycloalkyl or cycloalkenyl may be optionally substituted by one or more hydroxyl or C1-16 Alkyl groups; R represents hydrogen or C1-16 alkyl; X represents ethylene or a group of formula CRR wherein R and R independently represent hydrogen or C&lt;1-14 &gt;alkyl or R and R may together with the carbon atom to which they are attached form a C3-8 cycloalkyl group; R and R independently represent hydrogen or C1-14 alkyl; Z represents a bond, CO, SO2, CR R (CH2)n, (CH2)nCR R , CHR (CH2)nO, CHR (CH2)nS, CHR (CH2)nOCO, CHR (CH2&lt;/subsc</description><edition>7</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040325&amp;DB=EPODOC&amp;CC=US&amp;NR=2004058923A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040325&amp;DB=EPODOC&amp;CC=US&amp;NR=2004058923A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ANCLIFF RACHAEL ANNE</creatorcontrib><creatorcontrib>HARRISON LEE ANDREW</creatorcontrib><creatorcontrib>KEELING SUZANNE ELAINE</creatorcontrib><creatorcontrib>HODGSON SIMON TEANBY</creatorcontrib><creatorcontrib>COOK CAROLINE MARY</creatorcontrib><creatorcontrib>ELDRED COLIN DAVID</creatorcontrib><creatorcontrib>GORE PAUL MARTIN</creatorcontrib><creatorcontrib>LEWELL XIAO QING</creatorcontrib><creatorcontrib>JUDD DUNCAN BRUCE</creatorcontrib><creatorcontrib>ROBERTSON GRAEME MICHAEL</creatorcontrib><creatorcontrib>SWANSON STEPHEN</creatorcontrib><title>Morpholin-acetamide derivatives for the treatment of inflammatory diseases</title><description>Compounds of formula (I) wherein: R represents C1-16 alkyl, C2-6alkenyl, C2-6alkynyl, C2-6alkynyl-Y -, aryl-Y -, heteroaryl-Y -, aryl-(O)t-aryl-Y -, aryl-(O)t-heteroaryl-Y -, heteroaryl-(O)t-aryl-Y -, heteroaryl-(O)t-heteroaryl-Y -, C2-6 alkenyl-Y -, aryl-O-Y -, heteroaryl-O-Y -, C1-16 alkyl-SO2-Y -,M-Y -,J -Y -, -CN or C3-8 cycloalkyl-Y - or C3-8 cycloalkenyl-Y -, which cycloalkyl or cycloalkenyl may be optionally substituted by one or more hydroxyl or C1-16 Alkyl groups; R represents hydrogen or C1-16 alkyl; X represents ethylene or a group of formula CRR wherein R and R independently represent hydrogen or C&lt;1-14 &gt;alkyl or R and R may together with the carbon atom to which they are attached form a C3-8 cycloalkyl group; R and R independently represent hydrogen or C1-14 alkyl; Z represents a bond, CO, SO2, CR R (CH2)n, (CH2)nCR R , CHR (CH2)nO, CHR (CH2)nS, CHR (CH2)nOCO, CHR (CH2&lt;/subsc</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzL0KwjAUhuEsDqLewwHnQmwV6iiiiOCkzuVgvtBA_kgOBe9eBy_A6V0e3rm63lLJY_IuNvyCcHAGZFDcxOImVLKpkIwgKWAJiELJkovWcwgsqbzJuAquqEs1s-wrVr8u1Pp8ehwvDXIaUPP3HyHD895qvdW7ft92h033n_oAVjo2xA</recordid><startdate>20040325</startdate><enddate>20040325</enddate><creator>ANCLIFF RACHAEL ANNE</creator><creator>HARRISON LEE ANDREW</creator><creator>KEELING SUZANNE ELAINE</creator><creator>HODGSON SIMON TEANBY</creator><creator>COOK CAROLINE MARY</creator><creator>ELDRED COLIN DAVID</creator><creator>GORE PAUL MARTIN</creator><creator>LEWELL XIAO QING</creator><creator>JUDD DUNCAN BRUCE</creator><creator>ROBERTSON GRAEME MICHAEL</creator><creator>SWANSON STEPHEN</creator><scope>EVB</scope></search><sort><creationdate>20040325</creationdate><title>Morpholin-acetamide derivatives for the treatment of inflammatory diseases</title><author>ANCLIFF RACHAEL ANNE ; HARRISON LEE ANDREW ; KEELING SUZANNE ELAINE ; HODGSON SIMON TEANBY ; COOK CAROLINE MARY ; ELDRED COLIN DAVID ; GORE PAUL MARTIN ; LEWELL XIAO QING ; JUDD DUNCAN BRUCE ; ROBERTSON GRAEME MICHAEL ; SWANSON STEPHEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2004058923A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2004</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ANCLIFF RACHAEL ANNE</creatorcontrib><creatorcontrib>HARRISON LEE ANDREW</creatorcontrib><creatorcontrib>KEELING SUZANNE ELAINE</creatorcontrib><creatorcontrib>HODGSON SIMON TEANBY</creatorcontrib><creatorcontrib>COOK CAROLINE MARY</creatorcontrib><creatorcontrib>ELDRED COLIN DAVID</creatorcontrib><creatorcontrib>GORE PAUL MARTIN</creatorcontrib><creatorcontrib>LEWELL XIAO QING</creatorcontrib><creatorcontrib>JUDD DUNCAN BRUCE</creatorcontrib><creatorcontrib>ROBERTSON GRAEME MICHAEL</creatorcontrib><creatorcontrib>SWANSON STEPHEN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ANCLIFF RACHAEL ANNE</au><au>HARRISON LEE ANDREW</au><au>KEELING SUZANNE ELAINE</au><au>HODGSON SIMON TEANBY</au><au>COOK CAROLINE MARY</au><au>ELDRED COLIN DAVID</au><au>GORE PAUL MARTIN</au><au>LEWELL XIAO QING</au><au>JUDD DUNCAN BRUCE</au><au>ROBERTSON GRAEME MICHAEL</au><au>SWANSON STEPHEN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Morpholin-acetamide derivatives for the treatment of inflammatory diseases</title><date>2004-03-25</date><risdate>2004</risdate><abstract>Compounds of formula (I) wherein: R represents C1-16 alkyl, C2-6alkenyl, C2-6alkynyl, C2-6alkynyl-Y -, aryl-Y -, heteroaryl-Y -, aryl-(O)t-aryl-Y -, aryl-(O)t-heteroaryl-Y -, heteroaryl-(O)t-aryl-Y -, heteroaryl-(O)t-heteroaryl-Y -, C2-6 alkenyl-Y -, aryl-O-Y -, heteroaryl-O-Y -, C1-16 alkyl-SO2-Y -,M-Y -,J -Y -, -CN or C3-8 cycloalkyl-Y - or C3-8 cycloalkenyl-Y -, which cycloalkyl or cycloalkenyl may be optionally substituted by one or more hydroxyl or C1-16 Alkyl groups; R represents hydrogen or C1-16 alkyl; X represents ethylene or a group of formula CRR wherein R and R independently represent hydrogen or C&lt;1-14 &gt;alkyl or R and R may together with the carbon atom to which they are attached form a C3-8 cycloalkyl group; R and R independently represent hydrogen or C1-14 alkyl; Z represents a bond, CO, SO2, CR R (CH2)n, (CH2)nCR R , CHR (CH2)nO, CHR (CH2)nS, CHR (CH2)nOCO, CHR (CH2&lt;/subsc</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2004058923A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Morpholin-acetamide derivatives for the treatment of inflammatory diseases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T17%3A03%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ANCLIFF%20RACHAEL%20ANNE&rft.date=2004-03-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2004058923A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true